Published online before print July 2, 2007, doi: 10.1161/CIRCULATIONAHA.106.680421
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:427-433.)
© 2007 American Heart Association, Inc.
Vascular Medicine |
Prognostic Value of Troponins in Acute Pulmonary Embolism
A Meta-Analysis
From the Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Università di Perugia, Perugia, Italy.
Correspondence to Dr Cecilia Becattini, Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, University of Perugia, Via G. Dottori 1, 06129 Perugia, Italy. E-mail cecilia.becattini{at}unipg.it
Received December 13, 2006; accepted May 11, 2007.
Background— Whether elevated serum troponin levels identify patients with acute pulmonary embolism at high risk of short-term mortality or adverse outcome is undefined.
Methods and Results— We performed a meta-analysis of studies in patients with acute pulmonary embolism to assess the prognostic value of elevated troponin levels for short-term death and adverse outcome events (composite of death and any of the following: shock, need for thrombolysis, endotracheal intubation, catecholamine infusion, cardiopulmonary resuscitation, or recurrent pulmonary embolism). Unrestricted searches of MEDLINE and EMBASE bibliographic databases from January 1998 to November 2006 were performed using the terms "troponin" and "pulmonary embolism." Additionally, review articles and bibliographies were manually searched. Cohort studies were included if they had used cardiac-specific troponin assays and had reported on short-term death or adverse outcome events. A random-effects model was used to pool study results; funnel-plot inspection was done to evaluate publication bias; and I2 testing was used to test for heterogeneity. Data from 20 studies (1985 patients) were included in the analysis. Overall, 122 of 618 patients with elevated troponin levels died (19.7%; 95% confidence interval [CI], 16.6 to 22.8) compared with 51 of 1367 with normal troponin levels (3.7%; 95% CI, 2.7 to 4.7). Elevated troponin levels were significantly associated with short-term mortality (odds ratio [OR], 5.24; 95% CI, 3.28 to 8.38), with death resulting from pulmonary embolism (OR, 9.44; 95% CI, 4.14 to 21.49), and with adverse outcome events (OR, 7.03; 95% CI, 2.42 to 20.43). Elevated troponin levels were associated with a high mortality in the subgroup of hemodynamically stable patients (OR, 5.90; 95% CI, 2.68 to 12.95). Results were consistent for troponin I or T and prospective or retrospective studies.
Conclusions— Elevated troponin levels identify patients with acute pulmonary embolism at high risk of short-term death and adverse outcome events.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  K. M. Janata, J. M. Leitner, N. Holzer-Richling, A. Janata, A. N. Laggner, and B. Jilma Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism Eur. Respir. J., December 1, 2009; 34(6): 1357 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Moores Medical Uncertainty: Informing Decision Making for Patients With Acute Pulmonary Embolism Chest, October 1, 2009; 136(4): 952 - 953. [Full Text] [PDF]
|
|
|
|
|
|
D. Jimenez, F. Uresandi, R. Otero, J. L. Lobo, M. Monreal, D. Marti, J. Zamora, A. Muriel, D. Aujesky, and R. D. Yusen Troponin-Based Risk Stratification of Patients With Acute Nonmassive Pulmonary Embolism: Systematic Review and Metaanalysis Chest, October 1, 2009; 136(4): 974 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Fisher and P. A Corris Identification of those at risk after acute pulmonary embolism Thorax, October 1, 2009; 64(10): 832 - 833. [Full Text] [PDF]
|
|
|
|
|
|
J-C Lega, Y Lacasse, L Lakhal, and S Provencher Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis Thorax, October 1, 2009; 64(10): 869 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Sanchez, B. Planquette, and G. Meyer Update on acute pulmonary embolism Eur. Respir. Rev., September 1, 2009; 18(113): 137 - 147. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Konstantinides Acute Pulmonary Embolism N. Engl. J. Med., December 25, 2008; 359(26): 2804 - 2813. [Full Text] [PDF]
|
|
|
|
 |
|
 S. V Konstantinides Acute pulmonary embolism revisited Postgrad. Med. J., December 1, 2008; 84(998): 651 - 658. [Full Text] [PDF]
|
|
|
|
|
|
A. Proudfoot, D. Melley, and P. L Shah Role of thrombolysis in haemodynamically stable patients with pulmonary embolism Thorax, October 1, 2008; 63(10): 853 - 854. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Klok, I. C. M. Mos, and M. V. Huisman Brain-Type Natriuretic Peptide Levels in the Prediction of Adverse Outcome in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 425 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Sanchez, L. Trinquart, I. Colombet, P. Durieux, M. V. Huisman, G. Chatellier, and G. Meyer Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review Eur. Heart J., June 2, 2008; 29(12): 1569 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V Konstantinides Acute pulmonary embolism revisited Heart, June 1, 2008; 94(6): 795 - 802. [Full Text] [PDF]
|
|
|
|
|
|
C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 454S - 545S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lankeit, C. Dellas, A. Panzenbock, N. Skoro-Sajer, D. Bonderman, M. Olschewski, K. Schafer, M. Puls, S. Konstantinides, and I. M. Lang Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Eur. Respir. J., May 1, 2008; 31(5): 1024 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lankeit, T. Kempf, C. Dellas, M. Cuny, H. Tapken, T. Peter, M. Olschewski, S. Konstantinides, and K. C. Wollert Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 1018 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z. Goldhaber Assessing the Prognosis of Acute Pulmonary Embolism: Tricks of the Trade Chest, February 1, 2008; 133(2): 334 - 336. [Full Text] [PDF]
|
|